What is the appropriate diagnostic work‑up and management for a 49‑year‑old Hispanic male with type 2 diabetes mellitus, hyperlipidemia, intermittent post‑prandial left upper quadrant pain, normal abdominal ultrasound, eosinophilia, and chronic use of the nonsteroidal anti‑inflammatory drug meloxicam, who has no medical insurance?

Diagnostic Work-Up and Management for Post-Prandial Left Upper Quadrant Pain with Eosinophilia

This patient requires upper endoscopy with esophageal biopsies to evaluate for eosinophilic esophagitis (EoE), immediate discontinuation of meloxicam due to NSAID-related gastrointestinal risk, and consideration of alternative pain management for his chronic knee pain. 1

Primary Diagnostic Concern: Eosinophilic Esophagitis

The combination of post-prandial upper abdominal pain and peripheral eosinophilia (10.5% = approximately 546 cells/μL) raises significant concern for eosinophilic esophagitis, even though his symptoms are atypical (left upper quadrant rather than classic dysphagia). 1

Why EoE Should Be Considered:

• Post-prandial pain pattern is consistent with esophageal pathology, though patients may not always report classic dysphagia symptoms 1
• Peripheral eosinophilia (>5% on differential) strongly suggests an eosinophilic disorder 1
• Normal abdominal ultrasound excludes biliary and hepatic structural pathology, making functional esophageal disease more likely 2
• EoE is increasingly recognized in adults and can present with non-specific upper abdominal discomfort rather than overt dysphagia 1

Required Diagnostic Procedure:

Upper endoscopy with esophageal biopsies is mandatory, even if the esophagus appears endoscopically normal. 1 The British Society of Gastroenterology guidelines specifically state that all adults undergoing endoscopy should have esophageal biopsies if they have symptoms suggestive of EoE, even with normal-appearing mucosa (GRADE: High, Strong recommendation). 1

Critical procedural detail: The patient should discontinue any proton pump inhibitors for at least 3 weeks before endoscopy to improve diagnostic accuracy and avoid false-negative results. 1 However, there is no indication he is currently on PPIs.

Immediate Medication Management: Stop Meloxicam

Discontinue meloxicam immediately due to significant gastrointestinal risk in this patient. 1

Risk Stratification for NSAID Complications:

This patient falls into the moderate-to-high risk category for NSAID-related gastrointestinal complications: 1

• Age 49 years (approaching higher risk threshold of ≥50 years)
• Chronic daily NSAID use (meloxicam 15 mg daily)
• Concurrent use of pioglitazone (thiazolidinediones may increase GI risk)
• Active upper GI symptoms

The estimated annualized incidence of NSAID-related ulcer complications is 2% with one risk factor and increases substantially with multiple factors. 1

Alternative Pain Management:

For chronic knee pain, consider: 1

• Non-NSAID analgesics (acetaminophen as first-line for degenerative arthritis)
• Topical NSAIDs (lower systemic absorption and GI risk)
• Physical therapy and weight management
• If NSAIDs are absolutely necessary after EoE evaluation, use the lowest effective dose of the least ulcerogenic NSAID with gastroprotection (PPI or misoprostol) 1

Secondary Differential Considerations

Other Causes of Eosinophilia with GI Symptoms:

While pursuing EoE evaluation, consider: 1

• Parasitic infections (particularly Giardia): Obtain stool ova and parasites, Giardia antigen testing 1
• Eosinophilic gastroenteritis: Would be evaluated during upper endoscopy with gastric and duodenal biopsies 1
• Medication-induced enteropathy: Meloxicam itself could contribute to enteropathy with eosinophilia 1

Functional Biliary Disorders:

If endoscopy with biopsies is negative for EoE and other pathology: 3

• Consider hepatobiliary scintigraphy (HIDA scan) with cholecystokinin stimulation and gallbladder ejection fraction calculation
• This can identify sphincter of Oddi dysfunction or acalculous cholecystitis in patients with normal ultrasound
• One study showed abnormal findings in >70% of patients with right upper quadrant pain and normal ultrasound 3

Important caveat: Left upper quadrant pain is less typical for biliary pathology, making this lower on the differential. 3, 2

Cost-Conscious Approach for Uninsured Patient

Given lack of insurance, prioritize diagnostic efficiency: 1

1. Single endoscopy with comprehensive biopsies (esophageal, gastric, duodenal) to evaluate multiple potential diagnoses simultaneously 1
2. Stool studies (ova and parasites, Giardia antigen) are relatively inexpensive screening tests 1
3. Discontinue meloxicam (no cost, immediate benefit) 1
4. Defer HIDA scan unless endoscopy is completely negative and symptoms persist 3

Treatment Algorithm if EoE is Confirmed:

Should endoscopy confirm EoE (≥15 eosinophils per high-power field): 1

First-line treatment options (choose based on cost and patient preference):

1. Proton pump inhibitor therapy: Twice daily dosing for 8-12 weeks (GRADE: Moderate, Strong recommendation) 1

   • Most cost-effective option for uninsured patient
   • Generic omeprazole or pantoprazole 40 mg twice daily

2. Topical corticosteroids: Budesonide or fluticasone (GRADE: High, Strong recommendation) 1

   • Higher efficacy but more expensive
   • Requires maintenance therapy due to high relapse rates after discontinuation 1

3. Dietary elimination therapy: Six-food elimination diet (GRADE: Moderate, Strong recommendation) 1

   • Requires dietitian support throughout elimination and reintroduction phases 1
   • May be challenging without insurance coverage for dietitian services

Follow-up endoscopy with biopsies while on treatment is required to assess histological response, as symptoms may not correlate with disease activity. 1

Key Clinical Pitfalls to Avoid:

• Do not assume normal ultrasound excludes all pathology: Functional disorders and mucosal diseases require additional testing 3, 2
• Do not continue NSAIDs in patients with unexplained GI symptoms and eosinophilia: This combination significantly increases complication risk 1
• Do not skip esophageal biopsies even if endoscopy appears normal: Up to 25% of EoE patients have normal-appearing mucosa 1
• Do not perform endoscopy while patient is on PPIs: This can mask EoE and lead to false-negative biopsies 1
• Do not rely on symptom improvement alone to gauge treatment response in EoE: Histological assessment is mandatory 1